Iterion Therapeutics
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Operating in biotechnology, pharmaceutical, therapeutics based in Greater Houston Area, Southern US, Iterion Therapeutics was founded in 2010.
Iterion Therapeutics is positioned in biotechnology, pharmaceutical, therapeutics, a segment that rewards a clear, focused offering.
The business is associated with Greater Houston Area, Southern US.
The company is listed at the Series_B stage of development.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $21.4M.
| Sector | Biotechnology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater Houston Area, Southern US |
| Founded | 2010 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $21,375,000 |
Website: iteriontherapeutics.com
Sign in to view the contact information we hold for Iterion Therapeutics.
Create a free account
Create a free account